RItuximab Long-Term DOSE Trial in Multiple Sclerosis - RIDOSE-MS
NCT03979456
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
DRUG:
Rituximab
Sponsor
Karolinska Institutet